While some weight loss may occur, Rybelsus is not FDA-approved for weight loss
Common side effects include pain at the injection site, nausea, and dizziness
Lipid improvements typically become statistically significant by 12-26 weeks
The combined activation of GIPR and GLP-1R by tirzepatide not only improved both glucose-dependent insulin secretion and glucose tolerance in mice 15 , but also showed significantly better efficacy than semaglutide and dulaglutide with regard to glucose control and weight loss 16,17
BPC 157 is a peptide thats been gaining popularity for its potential to help with recovery, gut health, and reducing inflammation
This allows KPV to directly access intracellular inflammatory pathways at nanomolar concentrations, inhibiting NF-B activation and reducing the duration of inflammatory signaling